Olanzapine

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on August 10, 2021.

Return to the list of Patented Medicine Litigation page.





Olanzapine

ZYPREXA, ZYPREXA INTRAMUSCULAR, ZYPREXA ZYDIS – Eli Lilly Canada Inc. (NOC Search)

Patents:

  • 1075687: NOVOPHARM, COBALT, SUN PHARMA, APOTEX, SANDOZ, MELIAPHARM, GENPHARM, TEVA
  • 1750687: APOTEX
  • 2041113: SUN PHARMA, APOTEX, SANIS HEALTH, MELIAPHARM, SUN PHARMA, COBALT, PHARMASCIENCE, SIGMACON, MELIAPHARM, PRO DOC, RATIOPHARM, DOMINION, SANDOZ, RIVA, NOVOPHARM, MYLAN, PHARMEL, GENPHARM, TEVA, NU-PHARM
  • 2214005: PHARMASCIENCE, RATIOPHARM, MELIAPHARM, APOTEX, SUN PHARMA, COBALT, TEVA, GENPHARM, NU-PHARM, SANIS HEALTH, SANDOZ, NOVOPHARM
  • 2216372: SUN PHARMA, APOTEX, COBALT, GENPHARM, TEVA, NU-PHARM, RATIOPHARM, MELIAPHARM
  • 2265712: COBALT, RATIOPHARM, APOTEX

APOTEX

COBALT

DOMINION

GENPHARM

MELIAPHARM

MYLAN

NOVOPHARM

NU-PHARM

PHARMASCIENCE

PHARMEL

PRO DOC

RATIOPHARM

RIVA

SANDOZ

SANIS HEALTH

SANIS HEALTH, MELIAPHARM, SUN PHARMA

SIGMACON

SUN PHARMA

TEVA


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property